Allspring Global Investments’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
Other funds holding COLL
EAM
VCM
Allspring Global Investments's COLL Position: Q1 2026 in Review
Allspring Global Investments increased its Collegium Pharmaceutical (COLL) stake by 11% in Q1 2026, buying an estimated $39.1K and bringing the position to 9,032 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #1527.
Allspring Global Investments first reported a position in COLL in Q4 2021 and has held it in 17 quarters since. The position peaked at $3.08M in Q3 2024. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.
- Allspring Global Investments held 9,032 shares of Collegium Pharmaceutical worth $300K as of Q1 2026.
- Allspring Global Investments bought 924 Collegium Pharmaceutical shares in Q1 2026, an estimated $39.1K.
- Collegium Pharmaceutical made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1527 holding.
- Allspring Global Investments first reported a position in Collegium Pharmaceutical in Q4 2021 and has held it in 17 quarters since.
- Allspring Global Investments's Collegium Pharmaceutical position peaked at $3.08M in Q3 2024.
- 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.
Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.